DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 8,809,311 B2 Mccord (45) Date of Patent: *Aug

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 8,809,311 B2 Mccord (45) Date of Patent: *Aug USOO8809311B2 (12) United States Patent (10) Patent No.: US 8,809,311 B2 McCord (45) Date of Patent: *Aug. 19, 2014 (54) NUTRITIONAL SUPPLEMENTS 2007/0065396 A1 3/2007 Morariu 2010.0113611 A1 5, 2010 Raederstorff et al. (76) Inventor: Darlene McCord, Coralville, IA (US) 2013,0005682 A1 1/2013 Raederstorff et al. (*) Notice: Subject to any disclaimer, the term of this FOREIGN PATENT DOCUMENTS patent is extended or adjusted under 35 EP O123637 A1 10, 1984 U.S.C. 154(b) by 0 days. EP 2O70545 A1 6, 2009 JP 2007 119431 A 5/2007 This patent is Subject to a terminal dis WO WOOO36936 A2 6, 2000 claimer. WO WO2004/032873 A2 4/2004 WO WO2006/020588 A1 2, 2006 (21) Appl. No.: 12/853,908 WO WO2008/006581 A2 1, 2008 WO WO20081286.29 A1 10, 2008 (22) Filed: Aug. 10, 2010 OTHER PUBLICATIONS (65) Prior Publication Data Elisabet Miro-Casas etal, Clinical, Chemistry,49:6,945-952, 2003.* Rietjens et al. Am. J. Phisiolo. Heart, Circ. Physiol. 292:H1931 US 2011 FOO34519 A1 Feb. 10, 2011 H1936, 2007, published first in Dec. 2006.* Pubmed, accessed Apr. 3, 2012.* PCT Search Report for PCT/US2010/045049, dated Jan. 28, 2011. Related U.S. Application Data Angelo, S. D., et al., Hydroxytyrosol, a natural antioxidant from olive oil, prevents protein damage induced by long-wave ultraviolet radia (60) Provisional application No. 61/313,487, filed on Mar. tion in melanoma cells, Free Radical Biology & Medicine, 2005, 12, 2010, provisional application No. 61/235.203, 908-919, 38. filed on Aug. 19, 2009, provisional application No. Fabiani, R., et al., Cancer chemoprevention by hydroxytyrosol iso lated from virgin olive oil through G1 cell cycle arrest and apoptosis, 61/232,503, filed on Aug. 10, 2009. European Journal of Cancer Prevention, 2002, 351-358, 11. Ragione, F. D., et al., Hydroxytyrosol, a Natural Molecule Occuring (51) Int. Cl. in Olive Oil, Induces Cytochrome c-Dependent Apoptosis, Bio A6 IK 45/06 (2006.01) chemical and Biophysical Research Communications, 2000, 733 A6 IK3I/98 (2006.01) 739, 278. A6 IK3I/40 (2006.01) Deiana, M., et al., Protective effect of hydroxytyrosol and its metabo A6 IK3 L/455 (2006.01) lite homovanillic alcohol on H2O2 induced lipid peroxidation in A6 IK3I/05 (2006.01) renal tubular epithelial cells, Food and Chemical Toxicology, 2008, A6 IK3I/445 (2006.01) 2984-2990, 46. A6 IK3I/It (2006.01) Fabiani, R., et al., Inhibition of Cell Cycle Progression by A6 IK3I/85 (2006.01) Hydroxytyrosol Is Associated with Upregulation of Cyclin-Depen dent Protein Kinase Inhibitors p21 WAF1/Cip1 and p27 Kip1 and (52) U.S. Cl. with Induction of Differentiation in HL60 Cells, The Journal of CPC ................. A61 K3I/05 (2013.01); A61K 45/06 Nutrition: Nutrition and Disease, 2008, 42-48. (2013.01); A61 K3I/198 (2013.01); A61 K Guichard, C., et al., Dihydroxyphenylethanol induces apoptosis by 31/401 (2013.01); A61 K3I/455 (2013.01); activating serine/threonine protein phosphatase PP2A and promotes A6 IK3I/4415 (2013.01); A61 K3I/I0 the endoplasmic reticulum stress response in human colon carcinoma (2013.01); A61 K3I/I85 (2013.01) cells, Carcinogenesis, 2006, 1812-1827, 27(9). USPC ........... 514/183; 514/345; 514/731: 514/562; Liu, Z. et al., Hydroxytyrosol protects retinal pigment epithelial cells 514/355; 514/578; 514/423: 514/711; 514/561; from acrolein-induced oxidative stress and mitochondrial dysfunc 568/763 tion, Journal of Neurochemistry, 2007, 2690-2700, 103. Manna, C., et al., Protective Effect of the Phenolic Fraction from (58) Field of Classification Search Virgin Olive Oils against Oxidative Stress in Human Cells, Journal of CPC ... A61K 2300/00; A61 K31/05; A61K 31/10: Agricultural and Food Chemistry, 2002, 6521-6526, 50. A61K 31/185; A61 K31/198; A61K 31/401; A61K 31/4415: A61 K31/455; A61K 45/06 (Continued) See application file for complete search history. Primary Examiner — Wu-Cheng Winston Shen (56) References Cited Assistant Examiner — Jean Cornet U.S. PATENT DOCUMENTS (74) Attorney, Agent, or Firm — McKee, Voorhees & Sease 4,871,550 A * 10/1989 Millman ....................... 424,601 (57) ABSTRACT 6,117.844. A 9, 2000 Fredrickson A process for improving the health of a subject, the process 6,165,475 A 12/2000 Crea et al. comprising orally administering a composition comprising 6, 197,308 B1 3, 2001 Crea et al. 6,309,652 B1 10/2001 Aeschbach et al. hydroxytyrosol to the subject to provide the subject with a 6,358,542 B2 3, 2002 Cuomo et al. daily dose of about 0.1 to about 750 ug hydroxytyrosol per kg 6,416,808 B1 7, 2002 Crea of body weight, and a dietary Supplement in dosage unit form 6,437,004 B1 8, 2002 Perricone for oral administration, the dosage unit form comprising a 6,746,706 B1 6/2004 van der Boom et al. 8,216,599 B2 7, 2012 Crea composition containing about 1 microgram to about 50 mil 2001/0001817 A1* 5/2001 Humes ....................... 604/892.1 ligrams hydroxytyrosol or an ester or salt thereof. 2004/0101507 A1 5, 2004 Predovan 2006/0257351 A1 11, 2006 Chiba 27 Claims, No Drawings US 8,809,311 B2 Page 2 (56) References Cited Sarsour, Ehab H., et al., “MnSOD activity regulates hydroxytyrosol induced extension of chronological lifespan'. American Aging Asso OTHER PUBLICATIONS ciation 2011, pp. 1-15. Haber, C. Andrew, et al., “N-acetylcysteine and taurine prevent Dog, T. L., Menopause: a review of botanical dietary Supplements, hyperglycemia-induced insulin resistance in vivo: possible role of The American Journal of Medicine, 2005, 98S-108S, 118(12B). oxidative stress'. Am J Physiol Endocrinol Metab 285 (2003), E744 Johnson, B. M.. In Vitro Formation of Quinoid Metabolites of the E753. Dietary Supplement Cimicifiaga racemosa (Black Cohosh), Chemi Victor, Victor M., et al., “N-acetylcysteine Protects Mice from Lethal cal Research in Toxicology, 2003, 838-846, 16(7). Endotoxemia by Regulating the Redox State of Immune Cells'. Free Fernandez-Bolanos et al., Potential use of olive by-products Extrac Radical Research, vol. 37 No. 9 (Sep. 2003), pp. 919-929. tion of interesting organic compounds from olive oil waste, Grasasy Gonzalez-Correa, Jose Antonia, et al., “Neuroprotective effect of hydroxytyrosol acetate in rat brain slices subjected to hypoxia Aceites, 2006, 95-106, 57(1). reoxygenation”, Neuroscience Letters 446 (2008), 143-146. Scalbert, Augustin, et al., “Absorption and metabolism of Vissers, Maud N., et al., “Olive Oil Phenols Are Absorbed in polyphenols in the gut and impact on health'. Biomed Pharmacother Humans'. American Society for Nutritional Sciences, 2002, pp.409 56 (2002), 276-282. 417. Visioli, Fancesco, et al., “Antioxidant and Other Biological Activities Bisignano, Giuseppe, et al., “On the In-vitro Antimicrobial Activity of Olive Mill Waste Waters”. J. Agric. Food Chem. 1999, 47, 3397 of Leuropein and Hydroxytyrosol'. J. Pharm. Pharmacol. 1999, 51: 3401. 971-974 Haloui, Ehsen, et al., “Hydroxytyrosol and oleuropein from olive Webb, K.E., et al., “Peptide absorption: a review of current concepts leaves: Potent anti-inflammatory and analgesic activities'. Journal of and future perspectives”, J Anim Sci 1992, 70:3248-2357. Pereira, Ana Paula, et al., “Phenolic Compounds and Antimicrobial Food, Agriculture & Environment, vol. 9 (3 & 4) (2011), 128-133. Activity of Olive (Olea europaea L. Cv. Cobrancosa) Leaves'. Mol Granados-Principal, Sergio, et al., “Hydroxytyrosol: from laboratory ecules 2007, 12, 1153-1162. investigations to future clinical trials'. Nutrition Reviews vol. 68 (4), Romani, Annalisa, et al., “Polyphenolic Content in Five Tuscany 2010: 191-206. Cultivars of Olea europaea L., J. Argic. Food Chem. 1999, 47. Zhu, Lu, et al., “Hydroxytyrosol protects against Oxidative damage 964-967. by simultaneous activation of mitochondrial biogenesis and phase II Walter, W.M., Jr., et al., “Preparation of Antimicrobial Compounds detoxifying enzyme systems in retinal pigment epithelial cells'. Jour by Hydrolysis of Oleuropein from Green Olives'. Applied nal of Nutritional Biochemistry (2010), pp. 1-10. Microbiology, Nov. 1973, vol. 26, No. 5, p. 773-776. Zanichelli, Dario, et al., “Inhibition of Staphylococcus aureus by Capasso, Renato, et al., “Production of Glucose and Bioactive Oleuropein Is Mediated by Hydrogen Peroxide'. Journal of Food Aglycone by Chemical and Enymatic Hydrolysis of Purified Protections, vol. 68, No. 7, 2005, pp. 1492-1496. Oeluropein from Olea europea”, Applied Biochemistry and Washington, Jennifer M., et al., “L-Proline induces differentiation of Biotechnology, vol. 61, 1996, pp. 365-377. ES cells: a novel role for anamino acid in the regulation of pluripotent Matthews, D.M., et al... “Protein absorption”. J. clin. Path. 24. Suppl. cells in culture”, Am J Physiol Cell Physiol 298 (2010), C982-C992. (Roy. Coll. Path.), 5, 2012, pp. 29-40. Tuck, Kellie L., et al., “Major phenolic compounds in olive oil: EP0123637, Soto Lucien English Abstract, 1984. metabolism and health effects”, Journal of Nutritional Biochemistry JP2007 119431, Ichimaru Pharcos English Abstract, 2005. 13 (2002), 636-644. McCord, Darlene, PCT/US2010/045049 filed Jan. 12, 2012, “The SarSour, Ehab H., et al., “Manganese Superoxide Dismutase Regu Extended Europeans Search Report', dated Mar. 19, 2013. lates a Metabolic Switch during the Mammalian Cell Cycle”, 2012, pp. OF1-OF10. * cited by examiner US 8,809,311 B2 1. 2 NUTRITIONAL SUPPLEMENTS sodium ions into the cells interior. Repair of the cell's mem brane and improvement in the cells environment to more CROSS-REFERENCE TO RELATED homeostatic conditions are paramount to Survival APPLICATIONS Quiescence is the counterpart to proliferation and is a nor mal part of the cell cycle. The cell's replicative cycle involves This application claims priority to U.S. Provisional Appli a myriad of molecular events that occur during the quiescent cation Ser.
Load more

Recommended publications
  • (12) STANDARD PATENT (11) Application No. AU 2010224615 B2 (19) AUSTRALIAN PATENT OFFICE
    (12) STANDARD PATENT (11) Application No. AU 2010224615 B2 (19) AUSTRALIAN PATENT OFFICE (54) Title Dietary supplement (51) International Patent Classification(s) A23K 1/175 (2006.01) A23K1/18 (2006.01) (21) Application No: 2010224615 (22) Date of Filing: 2010.02.12 (87) WIPONo: WO10/106351 (30) Priority Data (31) Number (32) Date (33) Country 0904584.0 2009.03.17 GB (43) Publication Date: 2010.09.23 (44) Accepted Journal Date: 2014.05.08 (71) Applicant(s) Calinnova Ltd (72) Inventor(s) Green, Malcolm Geoffrey (74) Agent / Attorney Davies Collison Cave, Level 14 255 Elizabeth Street, Sydney, NSW, 2000 (56) Related Art ARNBJERG, J. "Hypokalcaemi hos hest. En kasuistik med diskussion (Hypocalcemia in the horse. A case report)" Nord Vet Med, 1980, Volume 32, Issue 5 Pages 207-211 US 2003/0077254 A1 (RAMAEKERS) 24 April 2003 FR 2625415 A1 (UNICOR UNION COOP AGRICOLES) 07 July 1989 HUDSON, NPH et al., "Primary Hypothyroidism in Two Horses" Australian Veterinary Journal, 1999, Volume 77, Number 8, Pages 504-508 GRUBB, T.L. et al., "Hemodynamic Effects of Calcium Gluconate Administered to Conscious Horses" Journal of Veterinary Internal Medicine, 1996, Volume 10 Number 6 Pages 401-404 US 2008/0014304 A1 (ZELLER et al.) 17 January 2008 ANONYMOUS, "Finish Line Thia-cal" [Retrieved on 23 April 2013] Retrieved from internet <URL: http://www.doversaddlery.eom/finish-line-thia-cal-gallon/p/X1-22069/> published on 30 December 2005 ANONYMOUS, "Humavyte" [Retrieved on 23 April 2013] Retrieved from internet <URL: http://web.archive.org/web/20080719131829/http://www.ranvet.com.au/
    [Show full text]
  • Which Supplements Can I Recommend to My Osteoarthritis Patients?
    Rheumatology 2018;57:iv75iv87 RHEUMATOLOGY doi:10.1093/rheumatology/key005 Advance Access publication 1 March 2018 Which supplements can I recommend to my osteoarthritis patients? Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/suppl_4/iv75/4916021 by Stellenbosch University user on 27 May 2019 Xiaoqian Liu1,2, Jillian Eyles1,2,3, Andrew J. McLachlan4 and Ali Mobasheri5,6 Abstract OA is a chronic and disabling joint disease with limited evidence-based pharmacological treatment op- tions available that improve outcomes for patients safely. Faced with few effective pharmacological treat- ments, the use has grown of dietary supplements and complementary medicines for symptomatic relief among people living with OA. The aim of this review is to provide a summary of existing evidence and recommendations supporting the use of supplements for OA. Systematic reviews and randomized con- trolled trials investigating oral supplements for treating OA were identified. Limited research evidence supports recommendations for the oral use of Boswellia serrata extract and Pycnogenol, curcumin and methylsulfonylmethane in people with OA despite the poor quality of the available studies. Few studies adequately reported possible adverse effects related to supplementation, although the products were generally recognized as safe. Further high quality trials are needed to improve the strength of evidence to support this recommendation and better guide optimal treatment of people living with OA. Key words: osteoarthritis, supplements, self-management, treatment, recommendations, complementary medicines Rheumatology key messages . Limited evidence supports the use Boswellia serrata extract, Pycnogenol, curcumin and methylsulfonylmethane for OA. Available evidence does not support some widely used supplements such as glucosamine and chondroitin for OA.
    [Show full text]
  • MSM) Levels in Human Plasma Ling Lin1,2*, Dejian Ma1, Richard J
    ition & F tr oo OPEN ACCESS Freely available online u d N f S o c l i e a n n c r e u s o J ISSN: 2155-9600 Journal of Nutrition & Food Sciences Research Article Development and Application of an LC-MS/MS Method for Determining Methylsulfonylmethane (MSM) levels in Human Plasma Ling Lin1,2*, Dejian Ma1, Richard J. Bloomer3, Matthew Butawan3 , Webb A. Smith4,5, Charles R. Yates6 1Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, Memphis, TN, USA; 2Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China; 3Center for Nutraceutical and Dietary Supplement Research, School of Health Studies, University of Memphis, Memphis, TN, USA Savar; 4Department of Pediatrics, University of Tennessee College of Medicine, Memphis, TN, USA; 5Children’s Foundation Research Institute, LeBonheur Children’s Hospital, Memphis, TN, USA; 6The National Center for Natural Products Research, Oxford, MS, USA ABSTRACT Methylsulfonylmethane (MSM) isan organosulfur phytochemical widely used as a dietary supplement carrying structure/function claims that includethe promotion of joint health. Untargeted metabolomics studies using nuclear magnetic resonance (NMR) have identified MSM in plasma and urine. However, MS-based methodology is more suitable for pharmacokinetic studies designed to explore MSM’s concentration-effect relationship for purposes of establishing dosing guidelines. To address this deficiency, an LC-MS/MS method using MSM, deuterated MSM (MSM-d6, internal standard), and liquid-liquid extraction was developed and validated in accordance with international guidelines. The method proved well-suited for determining MSM levels in human plasma following chronic oral administration (1, 2, or 3 grams daily) for four weeks.
    [Show full text]
  • Dietary Supplements for Osteoarthritis Philip J
    Dietary Supplements for Osteoarthritis PHILIP J. GREGORY, PharmD; MORGAN SPERRY, PharmD; and AmY FRIEdmAN WILSON, PharmD Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska A large number of dietary supplements are promoted to patients with osteoarthritis and as many as one third of those patients have used a supplement to treat their condition. Glucosamine-containing supplements are among the most commonly used products for osteo- arthritis. Although the evidence is not entirely consistent, most research suggests that glucos- amine sulfate can improve symptoms of pain related to osteoarthritis, as well as slow disease progression in patients with osteoarthritis of the knee. Chondroitin sulfate also appears to reduce osteoarthritis symptoms and is often combined with glucosamine, but there is no reliable evi- dence that the combination is more effective than either agent alone. S-adenosylmethionine may reduce pain but high costs and product quality issues limit its use. Several other supplements are promoted for treating osteoarthritis, such as methylsulfonylmethane, Harpagophytum pro- cumbens (devil’s claw), Curcuma longa (turmeric), and Zingiber officinale (ginger), but there is insufficient reliable evidence regarding long-term safety or effectiveness. Am( Fam Physician. 2008;77(2):177-184. Copyright © 2008 American Academy of Family Physicians.) ietary supplements, commonly glycosaminoglycans, which are found in referred to as natural medicines, synovial fluid, ligaments, and other joint herbal medicines, or alternative structures. Exogenous glucosamine is derived medicines, account for nearly from marine exoskeletons or produced syn- D $20 billion in U.S. sales annually.1 These thetically. Exogenous glucosamine may have products have a unique regulatory status that anti-inflammatory effects and is thought to allows them to be marketed with little or no stimulate metabolism of chondrocytes.4 credible scientific research.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0225053 A1 Dushenkov Et Al
    US 20120225053A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0225053 A1 Dushenkov et al. (43) Pub. Date: Sep. 6, 2012 (54) COMPOSITIONS AND METHODS FOR THE A6IP 9/02 (2006.01) PREVENTION AND TREATMENT OF A6IP 7/06 (2006.01) CONDITIONS ASSOCATED WITH A63L/7008 (2006.01) NFLAMATION A638/48 (2006.01) A6IR 36/287 (2006.01) (76) Inventors: Slavik Dushenkov, Fort Lee, NJ A 6LX 3L/75 (2006.01) (US); Patricia Lucas-Schnarre, A638/39 (2006.01) Metuchen, NJ (US); Julie Beth A6II 35/60 (2006.01) Hirsch, Branchburg, NJ (US); A636/906 (2006.01) David Evans, Belle Mead, NY A6IR 36/16 (2006.01) (US); Kitty Evans, legal A6IR 36/258 (2006.01) representative, Merritt Island, FL A636/87 (2006.01) (US) A636/76 (2006.01) A636/736 (2006.01) (21) Appl. No.: 11/920,973 A636/8 (2006.01) A6IP 29/00 (2006.01) (22) PCT Filed: May 24, 2006 (52) U.S. Cl. ........ 424/94.65: 514/456; 514/62; 424/771; (86). PCT No.: PCT/USO6/2O542 514/54: 514/17.2: 424/523; 424/756; 424/752: 424/728; 424/766; 424/769; 424/735; 424/760 S371 (c)(1), (2), (4) Date: May 2, 2012 (57) ABSTRACT Related U.S. Application Data The present invention provides methods for preventing, treat ing, managing and/or ameliorating a condition associated (60) Provisional application No. 60/684,487, filed on May with inflammation (e.g., an inflammatory disorder) or a 24, 2005. symptom thereof, the methods comprising administering to a subject in need thereof an effective amount of a theaflavin Publication Classification composition and an effective amount of one or more therapies (51) Int.
    [Show full text]
  • Glucosamine + Chondroitin + MSM Supports Joint Health*
    Jarrow® QUICKReference Guide FORMULAS healthy living through science & education Glucosamine + Chondroitin + MSM Supports Joint Health* Glucosamine + Chondroitin + MSM Combination provides efficacious quantities of Glucosamine Sulfate, Chondroitin Sulfate, and MSM combined with Vitamin C and Manganese for joint health.* PRODUCT CATEGORY Joint Who Can Benefit From this Product? Supplement Facts Serving Size 4 Capsules Anyone with suboptimal joint function who wants to promote joint Amount Per Serving % DV mobility, flexibility, and comfort may find this product beneficial.* Vitamin C 60 mg 100% Manganese 1 mg 50% Glucosamine Sulfate • 2 KCI 2000 mg * Yielding: Glucosamine Sulfate 1500 mg What Distinguishes this Product? Potassium Chloride 500 mg Chondroitin Sulfate (low molecular weight) 1200 mg * • Sodium-Free Glucosamine Sulfate (from 1333 mg Chondroitin Sulfate Sodium) Methylsulfonylmethane 300 mg * • 1.5 g Glucosamine Sulfate and 1.2 g Chondroitin Sulfate Per Serving (providing 102 mg of organic sulfur) - Quantities consistent with clinical research * Daily Value not established. • Also Contains Vitamin C and Manganese Other Ingredients - Needed in the synthesis of collagen and cartilage Magnesium stearate (vegetable source), cellulose, and silicon dioxide. Capsule consists of gelatin. Contains: Shellfish (shrimp). No wheat, no gluten, no soybeans, no dairy, no egg, How Does Each Active Ingredient Function in no fish, no peanuts/tree nuts. this Product? Suggested Usage Glucosamine Stimulates proteoglycan production found in joint Take 4 capsules per day, or as directed by your qualified health care consultant. Sulfate cartilage* Chondroitin Attracts shock-absorbing fluid to proteoglycans* Note MSM A sulfur source for inclusion in joints* Do NOT use if allergic to shellfish. If you have a medical condition, are pregnant, lactating, or trying Vitamin C Needed for synthesis of collagen* to conceive, are under the age of 18, or are taking medications, consult your health care practitioner Manganese Needed for synthesis of cartilage* before using this product.
    [Show full text]
  • Guideline for the Management of Knee and Hip Osteoarthritis Second Edition
    Guideline for the management of knee and hip osteoarthritis Second edition racgp.org.au Healthy Profession. Healthy Australia. Guideline for the management of knee and hip osteoarthritis. Second edition Disclaimer The information set out in this publication is current at the date of first publication and is intended for use as a guide of a general nature only and may or may not be relevant to particular patients or circumstances. Nor is this publication exhaustive of the subject matter. Persons implementing any recommendations contained in this publication must exercise their own independent skill or judgement or seek appropriate professional advice relevant to their own particular circumstances when so doing. Compliance with any recommendations cannot of itself guarantee discharge of the duty of care owed to patients and others coming into contact with the health professional and the premises from which the health professional operates. Whilst the text is directed to health professionals possessing appropriate qualifications and skills in ascertaining and discharging their professional (including legal) duties, it is not to be regarded as clinical advice and, in particular, is no substitute for a full examination and consideration of medical history in reaching a diagnosis and treatment based on accepted clinical practices. Accordingly, The Royal Australian College of General Practitioners Ltd (RACGP) and its employees and agents shall have no liability (including without limitation liability by reason of negligence) to any users of the information contained in this publication for any loss or damage (consequential or otherwise), cost or expense incurred or arising by reason of any person using or relying on the information contained in this publication and whether caused by reason of any error, negligent act, omission or misrepresentation in the information.
    [Show full text]
  • Product Data Douglas Laboratories® 04/2012 1
    PRODUCT DATA DOUGLAS LABORATORIES® 04/2012 1 MSM Fundamental Sulfur Capsules DESCRIPTION MSM (Fundamental Sulfur) provided by Douglas Laboratories®, contains 750 mg of methylsulfonylmethane (MSM) per capsule. MSM, a derivative of DMSO, is a naturally occurring compound of biologically available sulfur. FUNCTIONS Sulfur is an indispensable element in human nutrition. As part of the amino acids methionine and cysteine, sulfur is required for the structural integrity and function of almost every protein in the body, including enzymes, serum proteins, and the keratin of skin, hair, and nails. Sulfur is also an essential element for the glycosaminoglycans of connective tissues and cartilage, and assumes a major role in liver detoxification as part of the hepatic sulfur conjugation pathways. Proper detoxification of xenobiotics, such as phenols, and many endogenous and foreign food- or air-borne compounds depends on an adequate supply of biologically active sulfur. Dietary MSM serves as a versatile donor of metabolically active sulfur for the synthesis of numerous organosulfur compounds and proteins in the body. As such, MSM helps maintain normal immune response, lung function, connective tissue metabolism, and muscle contraction. MSM occurs naturally in a variety of foods, such as fruits, vegetables, cereal grains, milk, and fish. However, MSM is volatile and easily lost during cooking. MSM is very well absorbed by the intestinal tract and rapidly distributed within the body. INDICATIONS MSM may be a useful dietary supplement for individuals desiring support of joint/connective tissue function, hair and skin support, and liver health. FORMULA (#MSMC) One capsule contains: Methylsulfonylmethane (MSM)* .................................... 750 mg *OptiMSM (distilled methylsulfonylmethane) is a proprietary ingredient exceeding industry standards for optimal purity.
    [Show full text]
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
    Updated June 07, 2021 Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Three categories of bulk drug substances: • Category 1: Bulk Drug Substances Under Evaluation • Category 2: Bulk Drug Substances that Raise Significant Safety Risks • Category 3: Bulk Drug Substances Nominated Without Adequate Support Updates to Categories of Substances Nominated for the 503B Bulk Drug Substances List1 • Add the following entry to category 2 due to serious safety concerns of mutagenicity, cytotoxicity, and possible carcinogenicity when quinacrine hydrochloride is used for intrauterine administration for non- surgical female sterilization: 2,3 o Quinacrine Hydrochloride for intrauterine administration • Revision to category 1 for clarity: o Modify the entry for “Quinacrine Hydrochloride” to “Quinacrine Hydrochloride (except for intrauterine administration).” • Revision to category 1 to correct a substance name error: o Correct the error in the substance name “DHEA (dehydroepiandosterone)” to “DHEA (dehydroepiandrosterone).” 1 For the purposes of the substance names in the categories, hydrated forms of the substance are included in the scope of the substance name. 2 Quinacrine HCl was previously reviewed in 2016 as part of FDA’s consideration of this bulk drug substance for inclusion on the 503A Bulks List. As part of this review, the Division of Bone, Reproductive and Urologic Products (DBRUP), now the Division of Urology, Obstetrics and Gynecology (DUOG), evaluated the nomination of quinacrine for intrauterine administration for non-surgical female sterilization and recommended that quinacrine should not be included on the 503A Bulks List for this use. This recommendation was based on the lack of information on efficacy comparable to other available methods of female sterilization and serious safety concerns of mutagenicity, cytotoxicity and possible carcinogenicity in use of quinacrine for this indication and route of administration.
    [Show full text]
  • Glucosamine Chondroitin MSM
    product monograph NPN: 80008779 3345-8 Class: Supplement Glucosamine Chondroitin MSM Ingredients (alphabetical) Medicinal: Chondroitin sulfate, glucosamine sulfate, MSM (methyl-sulfonyl-methane) Non-medicinal: Coating (dextrin, dextrose, lecithin, sodium carboxymethylcellulose, sodium citrate), croscarmellose sodium, microcrystalline cellulose, purified water, stearic acid, vegetable grade magnesium stearate Allergens Corn, shellfish, soy, starch Source Glucosamine from the hard shells of shell fish, Chondroitin sulfate from bovine trachea, MSM is a derivative of wood lignin. Uses Use as a symptomatic treatment for osteoarthritis. The more traditional glucosamine sulfate and chondroitin sulfate are used as restorative or anabolic agents for catilage [Bucci, 1994]. MSM provides some pain and anti-inflammatory relief, as well as sulfur for connective tissue enhancement. Recommended Amount Use 1 tablet TID. A workable reduced dosage can be tried for the maintenance phase based on the retention of treatment benefits. The dosage can gradually be reduced at the rate of 1 tablet per 3 months. Increase the dosage if pain returns. In the case of age-related osteoarthritis, it would probably be prudent to remain on at least 2 tablets per day indefinitely. Adverse Side Effects There are virtually no adverse side effects and no toxicity reported with glucosamine sulfate or chondroitin sulfate, both being endogenous to cartilage [Bucci, 1994]. Some have complained of initial gastric upset when using these substances, so recommend with meals. MSM is used at a reduced dose in this product compared to MSM used alone specifically for pain. MSM is not associated with adverse side effects. The overwhelming majority of people who have taken MSM have experienced no adverse effects.
    [Show full text]
  • 70596—Cool Command® Senior Horse Feed (Texturized)
    MULTI-FORM SENIOR TEXTURIZED Equine Supplement GUARANTEED ANALYSIS Crude Protein, min 14.0 % Phosphorus, min 0.5 % Lysine, min 0.79 % Copper, min 45 PPM Methionine, min 0.2 % Selenium, min 0.3 PPM Threonine, min 0.5 % Zinc, min 80 PPM Crude Fat, min 8.0 % Vitamin A, min 4,000 IU/LB Crude Fiber, max 20.0 % Vitamin D, min 400 IU/LB Acid Detergent Fiber, max 22.0 % Vitamin E, min 100 IU/LB Neutral Detergent Fiber, max 32.0 % Biotin, min 0.6 MG/LB Starch, max 13.0 % *Glucosamine HCL, min 500 MG/LB Sugars, max 7.2 % *Condroitin Sulfate, min 350 MG/LB Calcium, min 0.9 % *Methylsulfonylmethane, min 500 MG/LB Calcium, max 1.4 % *Not recognized as an essential dietary nutrient INGREDIENTS Grain products, roughage products, plant protein products, molasses products, forage products, processed grain by- products, vegetable oil, calcium carbonate, calcium phosphate, salt, L-lysine, glucosamine hydrochloride, methylsulfonylmethane, zinc proteinate, potassium chloride, vitamin E supplement, sodium carboxymethylcellulose, manganese proteinate, ascorbic acid, chondroitin sulfate, sodium sulfate, potassium sulfite, propylene glycol, copper proteinate, hydrolyzed yeast, natural flavor, artificial flavor, iron proteinate, propionic acid (a preservative), sorbic acid (a preservative), acetic acid (a preservative), benzoic acid (a preservative), selenium yeast, ferrous sulfate, calcium pantothenate, niacin supplement, mineral oil, zinc oxide, thiamine mononitrate, manganese sulfate, cobalt proteinate, riboflavin supplement, menadione nicotinamide bisulfite (source of vitamin K activity), vitamin A supplement, pyridoxine hydrochloride, copper sulfate, manganous oxide, vitamin B-12 supplement, folic acid, vitamin D-3 supplement, ethylenediamine dihydroiodide, biotin, menadione sodium bisulfite complex (source of vitamin K activity).
    [Show full text]